What To Expect From Castle Biosciences Inc (CSTL) Q4 2024 Earnings [Yahoo! Finance]
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The consensus estimate for Q4 2024 revenue is $81.91 million, and the earnings are expected to come in at $0.04 per share. The full-year 2024 revenue is expected to be $327.50 million and the earnings are expected to be $0.39 per share. More detailed estimate data can be found on the Forecast page Castle Biosciences Inc ( NASDAQ:CSTL ) Estimates Trends Warning! GuruFocus has detected 2 Warning Sign with CSTL. Over the past 90 days, revenue estimates for Castle Biosciences Inc ( NASDAQ:CSTL ) have increased from $326.31 million to $327.51 million for the full year 2024 and from $265.64 million to $274.09 million for 2025. Earnings estimates have also seen an upward revision, increasing from $0.30 per share to $0.39 per share for the full year 2024, and from $-2.12 per share to $-1.89 per share for 2025. Castle Biosciences Inc ( NASDAQ:CSTL ) Reported History In the previous quarter ending on 2024-09-30, Castle Biosciences Inc's ( NASDAQ:CSTL ) actual revenue was $85.78 millio
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- Is New Uveal Melanoma Data Elevating Castle Biosciences' DecisionDx-UM Platform Story (CSTL)? [Yahoo! Finance]Yahoo! Finance
- Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal MelanomaGlobeNewswire
- Castle Biosciences (CSTL): Valuation Check After Expert Panel Endorses DecisionDx-Melanoma Test [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences (NASDAQ:CSTL) had its price target raised by analysts at BTIG Research from $38.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
- Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer [Yahoo! Finance]Yahoo! Finance
CSTL
Earnings
- 11/3/25 - Beat
CSTL
Sec Filings
- 12/17/25 - Form 144
- 12/17/25 - Form 4
- 12/15/25 - Form 144
- CSTL's page on the SEC website